Back to Search Start Over

The Nuclear Factor-kappa B p50 subunit is involved in flow-induced outward arterial remodeling.

Authors :
van Keulen JK
Timmers L
van Kuijk LP
Retnam L
Hoefer IE
Pasterkamp G
Lim SK
de Kleijn DP
Source :
Atherosclerosis [Atherosclerosis] 2009 Feb; Vol. 202 (2), pp. 424-30. Date of Electronic Publication: 2008 Jun 05.
Publication Year :
2009

Abstract

Aims: Outward arterial remodeling is a structural enlargement of the artery that is associated with unstable inflammatory atherosclerotic lesions. Toll-like receptor (Tlr) activation is known as a key pathway in outward arterial remodeling. Tlr activation results in nuclear translocation of the transcription factor Nuclear Factor-kappa B (NF-kappaB) that controls the transcription of many inflammatory genes. The NF-kappaB subunit p50 is generally considered to be an inhibitory subunit of the NF-kappaB complex. We therefore hypothesize that NF-kappaB p50 inhibits outward arterial remodeling.<br />Methods and Results: Carotid artery ligation in mice, induced outward remodeling in contralateral arteries of NF-kappaB p50(-/-) (p50(-/-)) and wild type (WT) arteries. p50(-/-) arteries showed more outward arterial remodeling than WT arteries (19894.0+/-3136.7 microm(2) vs. 6120.7+/-2741.2 microm(2), respectively, P=0.006). In vitro, lipopolysaccharide induced higher cytokine expression levels in p50(-/-) cells compared to WT cells. In vivo, more outward remodeling in p50(-/-) arteries was associated with a decrease in collagen density and an increased influx of macrophages.<br />Conclusions: The NF-kappaB p50 subunit is involved in outward arterial remodeling. This is probably due to modulation of macrophage influx and adventitial collagen, leading to enhanced flow-induced outward arterial remodeling after targeted deletion of NF-kappaB subunit p50.

Details

Language :
English
ISSN :
1879-1484
Volume :
202
Issue :
2
Database :
MEDLINE
Journal :
Atherosclerosis
Publication Type :
Academic Journal
Accession number :
18617174
Full Text :
https://doi.org/10.1016/j.atherosclerosis.2008.05.049